Astaxanthin

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

astaxanthin esters extracted from Haematococcus pluvialis, Quantity: 40 mg (Equivalent: Astaxanthin (of Haematococcus pluvialis), Qty 4 mg); lecithin, Quantity: 100 mg; glutathione, Quantity: 10 mg; d-alpha-tocopherol, Quantity: 33.6 mg (Equivalent: d-alpha-tocopherol, Qty 50 IU); Linseed Oil, Quantity: 250 mg

Available from:

Ferngrove Pharmaceuticals Australia Pty Ltd

Pharmaceutical form:

Capsule, soft

Composition:

Excipient Ingredients: glycerol; vanillin; purified water; Gelatin; iron oxide red; Soya Oil; Flavour

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Enhance/promote/physical endurance/capacity/stamina ; Maintain/support physical endurance/capacity/stamina ; Maintain/support healthy eye function ; Maintain/support eye health ; Helps maintain/support eye retina health ; Maintain/support healthy eyesight/vision ; Helps enhance/promote general health and wellbeing ; Maintain/support general health and wellbeing ; Helps enhance/promote skin health ; Maintain/support skin health

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2023-02-06